Cambridge Investment Research Advisors’s Fidelity Enhanced International ETF FENI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.6M Buy
1,036,773
+32,654
+3% +$1.29M 0.1% 209
2026
Q1
$37.4M Buy
1,004,119
+386,971
+63% +$14.9M 0.1% 206
2025
Q4
$22.6M Buy
617,148
+54,963
+10% +$1.97M 0.06% 324
2025
Q3
$19.8M Buy
562,185
+41,411
+8% +$1.41M 0.05% 345
2025
Q2
$17.3M Buy
520,774
+107,151
+26% +$3.35M 0.05% 360
2025
Q1
$12.3M Buy
413,623
+377,324
+1,039% +$11.1M 0.04% 430
2024
Q4
$999K Buy
36,299
+3,937
+12% +$113K ﹤0.01% 1875
2024
Q3
$980K Sell
32,362
-1,876
-5% -$54.5K ﹤0.01% 1868
2024
Q2
$970K Buy
34,238
+6,056
+21% +$172K ﹤0.01% 1795
2024
Q1
$805K Buy
28,182
+1,922
+7% +$52.3K ﹤0.01% 1881
2023
Q4
$696K Buy
+26,260
New +$673K ﹤0.01% 1913

Other funds holding FENI

Cambridge Investment Research Advisors's FENI Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Fidelity Enhanced International ETF (FENI) stake by 3.3% in Q2 2026, buying an estimated $1.29M and bringing the position to 1,036,773 shares worth $41.6M. The position accounts for 0.1% of the portfolio, ranked #209.

Cambridge Investment Research Advisors first reported a position in FENI in Q4 2023 and has held it in 11 quarters since. 155 funds tracked by Wall St. Rank hold FENI as of Q2 2026.

  • Cambridge Investment Research Advisors held 1,036,773 shares of Fidelity Enhanced International ETF worth $41.6M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 32,654 Fidelity Enhanced International ETF shares in Q2 2026, an estimated $1.29M.
  • Fidelity Enhanced International ETF made up 0.1% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #209 holding.
  • Cambridge Investment Research Advisors first reported a position in Fidelity Enhanced International ETF in Q4 2023 and has held it in 11 quarters since.
  • 155 funds tracked by Wall St. Rank held Fidelity Enhanced International ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.